Donald Durden
Associate Professors · University of Nebraska Medical Center College of Medicine
Credentials: · · · ·
History
Hematology and Medical Oncology
Internal Medicine
University School of Medicine
Research
Review · Journal of Neuropathology & Experimental Neurology · 2006 · 423 citations
PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy
Journal of Biological Chemistry · 2002 · 279 citations
Cancer Research · 2008 · Last of 13 authors · 243 citations
8 papers
5 papers
5 papers
- JS
4 papers
- KI
4 papers
4 papers
3 papers
3 papers
Grants
- 2026–2027
Preclinical Development of Novel Dual EZH2-BRD4 Inhibitor for EZH2-Mutant Lymphoma
National Cancer Institute · R43
Contact PI · $385.1K · Biologica Llc
- 2017–2025
Dual PI3K/BRD4 Inhibitory Chemotype for Maximum Inhibition of MYC and Cancer
National Cancer Institute · R01
Contact PI · $2.3M · Wake Forest University Health Sciences
- 2017–2025
Role of PTEN and PI-3 Kinase in Medulloblastomagenesis
National Cancer Institute · R01
Contact PI · $1.6M · Wake Forest University Health Sciences
- 2016–2020
Food and Drug Administration · R01
Contact PI · $500K · University of California, San Diego
Clinical trials
- 2010–2019
A Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas
Principal investigator · Completed · Phase 2
Wake Forest University Health Sciences
- 2007–2011
Study chair · Completed · Phase 1
Semafore Pharmaceuticals